rs764520289

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM1BP4_ModerateBP6BS2

The NM_000321.3(RB1):​c.2222G>A​(p.Arg741His) variant causes a missense change. The variant allele was found at a frequency of 0.0000259 in 1,118,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R741C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., cov: 24)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

RB1
NM_000321.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 4.66

Publications

1 publications found
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1 Gene-Disease associations (from GenCC):
  • hereditary retinoblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • retinoblastoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • melanoma
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 25 uncertain in NM_000321.3
BP4
Computational evidence support a benign effect (MetaRNN=0.16017938).
BP6
Variant 13-48465008-G-A is Benign according to our data. Variant chr13-48465008-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 581005.
BS2
High AC in GnomAdExome4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RB1NM_000321.3 linkc.2222G>A p.Arg741His missense_variant Exon 22 of 27 ENST00000267163.6 NP_000312.2 P06400A0A024RDV3
RB1NM_001407165.1 linkc.2222G>A p.Arg741His missense_variant Exon 22 of 27 NP_001394094.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RB1ENST00000267163.6 linkc.2222G>A p.Arg741His missense_variant Exon 22 of 27 1 NM_000321.3 ENSP00000267163.4 P06400

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111640
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000347
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000204
AC:
5
AN:
245098
AF XY:
0.0000151
show subpopulations
Gnomad AFR exome
AF:
0.0000632
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.0000268
AC:
27
AN:
1007328
Hom.:
0
Cov.:
34
AF XY:
0.0000254
AC XY:
13
AN XY:
511232
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26394
American (AMR)
AF:
0.00
AC:
0
AN:
38846
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18800
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27486
South Asian (SAS)
AF:
0.0000269
AC:
2
AN:
74216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3128
European-Non Finnish (NFE)
AF:
0.0000327
AC:
24
AN:
733964
Other (OTH)
AF:
0.00
AC:
0
AN:
40896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111640
Hom.:
0
Cov.:
24
AF XY:
0.0000393
AC XY:
2
AN XY:
50844
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29932
American (AMR)
AF:
0.00
AC:
0
AN:
8116
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3632
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3562
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
116
European-Non Finnish (NFE)
AF:
0.0000347
AC:
2
AN:
57654
Other (OTH)
AF:
0.00
AC:
0
AN:
1418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000301
Hom.:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:2
Nov 15, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Oct 25, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R741H variant (also known as c.2222G>A), located in coding exon 22 of the RB1 gene, results from a G to A substitution at nucleotide position 2222. The arginine at codon 741 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Retinoblastoma Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.22
CADD
Uncertain
23
DANN
Benign
0.96
DEOGEN2
Benign
0.39
T;.
Eigen
Benign
-0.24
Eigen_PC
Benign
0.038
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
-0.72
N;.
PhyloP100
4.7
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
0.0
N;.
REVEL
Benign
0.28
Sift
Benign
0.52
T;.
Sift4G
Benign
0.69
T;.
Polyphen
0.022
B;.
Vest4
0.18
MutPred
0.50
Gain of catalytic residue at L743 (P = 0.0097);Gain of catalytic residue at L743 (P = 0.0097);
MVP
0.64
MPC
0.56
ClinPred
0.11
T
GERP RS
5.5
Varity_R
0.37
gMVP
0.33
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs764520289; hg19: chr13-49039144; COSMIC: COSV57295166; API